Bio Rad Laboratories IncChange company Symbol lookupSelect an option...BIO Bio Rad Laboratories IncVTNR Vertex Energy IncBFI Burgerfi International IncATRO Astronics CorpBHR Braemar Hotels & Resorts IncNBSTU Newbury Street Acquisition CorpSKX Skechers USA IncIGICW International General Insurance Holdings Equity Warrants 17th March 2025 *W EXP 03/17/2025NHIC Newhold Investment II CorpMMI Marcus & Millichap IncGo
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. Its segments include Life Science and Clinical Diagnostics. Its Life Science segment markets and develops, manufactures and markets approximately 9,000 reagents, apparatus and laboratory instruments that serve a global customer base. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Its Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. It supplies approximately 3,000 different products that cover over 300 clinical diagnostic tests to the in vitro diagnostics (IVD) test market.
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| April 28, 2022 | Q1 2022 Earnings Release | $4.94 | $2.80 to $3.98 | $5.21 |
| February 10, 2022 | Q4 2021 Earnings Release | $3.21 | $2.79 to $2.93 | $4.01 |
| October 28, 2021 | Q3 2021 Earnings Release | $3.71 | $2.30 to $2.82 | $3.00 |
| July 29, 2021 | Q2 2021 Earnings Release | $3.54 | $1.90 to $3.19 | $1.61 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.
, , , Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.